David Newman-Toker, MD
David
Newman-Toker is Assistant Professor of Neurology with Joint Appointments
in Ophthalmology, Otolaryngology, Health Policy & Management, and Biomedical
Information Sciences at the Johns Hopkins University School of Medicine.
He received his B.S. from Yale University in Molecular Biophysics and
Biochemistry and his M.D. from the University of Pennsylvania School of
Medicine. After completing his Neurology residency at the Massachusetts
General Hospital, he went on to complete fellowships in Neuro-ophthalmology
at the Massachusetts Eye & Ear Infirmary and Neuro-otology at the Johns
Hopkins Hospital. He is currently a Ph.D. candidate in the Graduate Training
Program in Clinical Investigation, a program jointly administered by the
Johns Hopkins School of Medicine and the Johns Hopkins Bloomberg School
of Public Health. Dr. Newman-Toker's clinical focus is on disorders of the brainstem and cranial nerves, including unexplained visual loss, double vision, dizziness, and facial paralysis. He also specializes in the evaluation and treatment of headaches and facial pain. His research focus is on diagnostic errors, decision modeling, and designing clinical algorithms and bedside decision support systems that reduce misdiagnosis, particularly in primary care settings. He currently holds an NIH K23 career development award from the National Center for Research Resources entitled "Building a New Model for Diagnosis of ED Dizzy Patients" (1K23RR17324-01), funding a five-year project examining the frequency and probable cause of misdiagnosis of dizzy patients presenting to the Emergency Department, and possible ways to reduce such diagnostic errors.
Dr. Newman-Toker is currently the principal investigator of a five-year project entitled "Building a New Model for Diagnosis of ED Dizzy Patients" intended to examine the frequency and probable cause of misdiagnosis of dizzy patients presenting to the Emergency Department, and possible ways to reduce such diagnostic errors. |